NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes
Authors:
- L. A. TrepanierLTL. A. Trepanier
- J. L. MillerJMJ. L. Miller
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 30 (12) , 1111-1121
Abstract
1. Reduction of hydroxylamine drug metabolites by NADH-dependent hydroxylamine reductase (NDHR) has been suggested to be involved in the pathogenesis of idiosyncratic sulphonamide toxicity in humans. The dog represents a naturally occurring clinical model for sulphonamide toxicity in humans. he purpose of these studies, therefore, was to characterize the presence of hepatic NADH-dependent hydroxylamine reductase activity in the dog and to compare this activity with that found in humans. 2. NDHR activity was characterized by the presence of two enzymes in both dog and human liver microsomes, with comparable estimates of Km (Km1 = 75 microM, Km2 = 404 microM in dog; Km1 = 69 microM, Km2 = 503 microM in human). Estimates of maximal velocity were significantly, but not dramatically, higher for dog NDHR (Vmax1 = 2.09 nmole mg(-1) min(-1) Vmax2 = 4.58 nmole mg(-1) min(-1) compared with human NDHR (Vmax1 = 0.42 nmole mg(-1) min(-1), Vmax2 = 1.56 nmole mg(-1) min(-1)). NDHR in dog, as in humans, preferred NADH to NADPH, was more active at pH 6.3 than at 7.4 and was not inhibited by carbon monoxide, azide, anaerobic conditions, the CYP substrate inhibitors tolbutamide, dextromethorphan, or erythromycin, or antibodies directed against CYP2C, CYP2D or CYP3A. 3. It is concluded that two forms of NDHR are present in dog and humans with similar biochemical characteristics. Although NDHR activity has been attributed to a CYP2D isoform in pig, there is no evidence for involvement of CYP450 in the reduction of sulphamethoxazole hydroxylamine in either dogs or humans.Keywords
This publication has 13 references indexed in Scilit:
- Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and managementVeterinary Dermatology, 1999
- Expression and Characterization of Canine Cytochrome P450 2D15Archives of Biochemistry and Biophysics, 1998
- Isolation and Characterization of the Protein Components of the Liver Microsomal O2-insensitive NADH-Benzamidoxime ReductaseJournal of Biological Chemistry, 1997
- Cytosolic arylamine n-acetyltransferase (NAT) deficiency in the dog and other canids due to an absence of NAT genesBiochemical Pharmacology, 1997
- N-Oxygenation of Primary Amines and Hydroxylamines and Retroreduction of Hydroxylamines by Adult Human Liver Microsomes and Adult Human Flavin-Containing Monooxygenase 3Chemical Research in Toxicology, 1996
- Microsomal Catalyzed N-Hydroxylation of Guanabenz and Reduction of the N-Hydroxylated Metabolite: Characterization of the Two Reactions and Genotoxic Potential of Guanoxabenz1Chemical Research in Toxicology, 1996
- Time-course of toxicity of reactive sulfonamide metabolitesToxicology, 1995
- An in vitro investigation of predisposition to sulphonamide idiosyncratic toxicity in dogsVeterinary Research Communications, 1990
- Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomesArchives of Biochemistry and Biophysics, 1974
- Reduced Pyridine nucleotide-dependent N-hydroxy amine oxidase and reductase activities of hepatic microsomesArchives of Biochemistry and Biophysics, 1973